Maryland Retiree Prescription Drug Program Stays Active
The state's Medicare Part D transition for retirees continues as a federal court denies a request for an injunction.
Updated on Oct. 28, 2026 in Substance Abuse
Live Poll
Do you believe states should outsource the administration of retiree benefit programs to private companies?
A federal judge has denied a request for an injunction to block Maryland's state retiree prescription drug program. The transition, which moved retirees to Medicare Part D plans last year, remains in effect while legal challenges regarding benefit administration continue.
Why it matters
This ruling impacts how Maryland retirees access and pay for medications under the state's transition to Medicare Part D. Disagreements remain regarding the effectiveness of the reimbursement system managed by a private vendor.
The federal court decision follows a cost-benefit analysis where the state estimated the use of a private vendor at $775,000 compared to $3 million for internal management. It remains unknown how the court will ultimately rule on claims that the state failed to implement required reimbursement programs.
The players
Maryland Department of Budget and Management
The state agency responsible for the administration and oversight of public employee benefits and financial programs.
Via Benefits
A private benefits administration company contracted by the state to manage portions of the prescription drug program.
The details
Maryland's program transitioned eligible state retirees from its prior prescription coverage to Medicare Part D plans supplemented by state financial assistance. The state employs a private company, Via Benefits, to manage the administration and reimbursement process. Retirees must navigate specific paperwork to request financial relief for prescription costs that exceed established state limits.
Timeline
Last year: Maryland transitioned eligible retirees to Medicare Part D plans.
Wednesday: A federal judge denied the requested injunction.
Health Landscape
This case highlights the ongoing challenges of integrating state-specific retiree health benefits with the federal Medicare Part D structure. It reflects a broader trend of state agencies seeking cost efficiencies through private vendor partnerships to manage complex prescription coverage transitions.
Retirees currently managing prescription costs should ensure they are familiar with the reimbursement paperwork requirements through Via Benefits. If you are experiencing unexpected out-of-pocket costs between $1,000 and $2,000, consult with a financial advisor or your physician regarding your coverage options.
The takeaway
The court's denial of the injunction means the current prescription drug program administration remains in place. Retirees should carefully track all prescription receipts and ensure they follow the state's specific reimbursement procedures to mitigate out-of-pocket expenses.
Further reading
For more information on navigating coverage changes, visit Substance Abuse.
Source note: This article includes information reported by WBFF.
Live Poll
Do you believe states should outsource the administration of retiree benefit programs to private companies?
